Botanical species · safety record

Rosa canina

The EFSA Compendium of Botanicals holds 4 constituent measurements and 2 adverse-effect records for Rosa canina. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Rosa canina L.

4Constituent measurements

2Safety records

4Cited sources

551Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 551 licensed products naming Rosa canina as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Extract Type TBA
Fresh

Source material stated

Aerial parts
Berry/Berries
Buds
Dried fruit
Edible fruit part
Flower
Flower buds
Flowers and leaves

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Gallotannins	Flowering top	Solvent extraction	—	HPLC-DAD	Resolve DOI
Matairesinol	Fruit unspecified	Solvent extraction	22 Microgram/kilogram	Gaschromatography (GC)	No resolvable identifier
P-coumaric acid	Fruit unspecified	Solvent extraction	—	HPLC with standard detection methods	No resolvable identifier
Secoisolarisiresinol	Fruit unspecified	Solvent extraction	788 Microgram/kilogram	Gaschromatography (GC)	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive: pancreas	Fruit unspecified	Solvent extraction	—	In vitro	No resolvable identifier
Digestive	Digestive: pancreas	Fruit unspecified	Solvent extraction	—	In vitro	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Asghari, Behvar., Salehi, Peyman., Farimani, Mandi Moridi., Ebrahimi, Samad Nejad. alpha-Glucosidase Inhibitors from Fruits of Rosa canina L.. Records of natural products, 2015, vol. 9, no. 3, p. 276-283.
Valsta, Liisa M., Kilkkinen, Annamari., Mazur, Witold., Nurmi, Tarja., Lampi, Anna-Maija., Ovaskainen, Marja-Leena., Korhonen, Tommi., Adlercreutz, Herman., Pietinen, Pirjo. Phyto-oestrogen database of foods and average intake in Finland. British Journal of Nutrition, 2003, p. S31-S38.
Turkben, Cihat., Uylaser, Vildan., Incedayi, Bige., Celikkol, Isil. Effects of different maturity periods and processes on nutritional components of rose hip (Rosa canina L.) . Journal of food agriculture & environment, 2010, vol. 8, no. 1, p. 26-30.
Ieri, Francesca., Innocenti, Marzia., Possieri, Lucia., Gallori, Sandra., Mulinacci, Nadia. Phenolic composition of bud extracts of Ribes nigrum L., Rosa canina L. and Tilia tomentosa M.. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2015, vol. 115, p. 1-9. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature